There are several sources of obtaining stem cells such as spinal marrow, umbilical blood, skin and genital glands. Special attention is paid to excessive blastocysts, which have been prepared for extracorporal fertilization, but unused. Application of these blastocysts predetermines following a set of ethical rights and norms, valid in all countries where their medical usage is legitimated. An official approval of mother or both parents for usage of excessive blastocysts is obligatory required. They should be well aware of medical consequences of their action. This document should be confirmed by national or departmental ethical committee or administrative authority. The Therapeutic Goods Administration regulates application of human tissues in the medicine. “Scientists in Australia and around the world are investigating the potential of different classes of stem cells to repair tissues by inducing them to become the cells needed for repair or replacement of damaged or diseased tissues and organs.” (Sanderson, 2008) At present only umbilical blood stem cells are unused for curing patients in Australia, as this field of medicine has not sufficient quantity of scientific research programs. The scientists consider that the base for stem cell therapy in clinics will be prepared within the following ten – fifteen years. It will help to avoid unforeseen causae mortis among the patients under investigation.
In the international documents necessity of full exclusion of germ purchase and sale is especially underlined, as it prevents female exploitation, humiliation of her self-esteem, deceit by means of pseudo diagnostics. Anonymity of genetic parents of stem cells should be preserved in order not to break privacy of donors and recipients. It concerns for donors of all types of stem cells. This principle promotes further development of stem cells medicine, mitigating some